NCT02960347View on ClinicalTrials.gov

Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Ohtahara Syndrome
Interventions
DEVICE

High-definition (HD) transcranial direct current stimulator, HD-tDCS with 4x1 HD adaptor

Non-invasive focal neuromodulation

Trial Locations (1)

9103702

Herzog Hospital, Jerusalem

All Listed Sponsors
collaborator

The City College of New York

OTHER

lead

Herzog Hospital

OTHER

NCT02960347 - Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures | Biotech Hunter | Biotech Hunter